Naïve Bayes classifier predicts functional microRNA target interactions in colorectal cancer

Raheleh Amirkhah1, Ali Farazmand, Shailendra K Gupta

  • 1Department of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran.

Molecular Biosystems
|June 19, 2015
PubMed

Insights

Researchers developed CRCmiRTar, a novel algorithm for predicting microRNA (miRNA) targets in colorectal cancer (CRC). This tool improves accuracy in identifying crucial miRNA-mRNA interactions for potential therapeutic strategies.

Area of Science:

  • Genomics
  • Bioinformatics
  • Molecular Biology

Background:

  • MicroRNA (miRNA) expression changes are observed in various cancers, including colorectal cancer (CRC).
  • Existing computational miRNA target prediction methods lack accuracy due to generalized pattern assumptions.
  • Tissue-specific miRNA target recognition is an emerging area of research.

Purpose of the Study:

  • To develop a novel computational algorithm for predicting miRNA-target interactions specifically in colorectal cancer (CRC).
  • To identify features that define CRC-specific miRNA-target interactions.
  • To improve the accuracy of miRNA target prediction in cancer research.

Main Methods:

  • Developed CRCmiRTar, a Naïve Bayes classifier for miRNA-target prediction in CRC.
  • Trained the algorithm using validated miRNA target interactions from CRC and other cancers.
  • Identified position-based, sequence, structural, and thermodynamic features for CRC-specific interactions.

Main Results:

  • CRCmiRTar demonstrated significantly improved performance (AUC, sensitivity) compared to existing machine learning algorithms.
  • Predicted 204 functional miRNA-mRNA interactions involving 11 miRNAs and 41 mRNAs in CRC tissues.
  • The algorithm's accuracy was validated using miRNA and gene expression profiles from CRC tissues.

Conclusions:

  • CRCmiRTar offers a more accurate method for predicting disease-specific miRNA-target interactions.
  • The approach can be adapted for predicting miRNA targets in other diseases.
  • Identifying specific miRNA-target interactions may aid in discovering novel drug targets for CRC.